Application of high flow nasal catheter oxygen therapy in the treatment of AECOPD with hypercapnia

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900024595

Enrollment

Unknown

Registered

2019-07-18

Start date

2019-08-01

Completion date

Unknown

Last updated

2019-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute exacerbation of copd with hypercapnia

Interventions

treatment group:High-flow nasal cannula oxygen therapy

control group:Continuous low flow oxygen inhalation through nasal catheter

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.acute exacerbation of chronic obstructive pulmonary disease; 2.Arterial PCO2 is greater than 45 mmHg, Arterial PO2 is lower than 60 mmHg; 3.Conscious mind; 4.Willing to participate in this study.

Exclusion criteria

Exclusion criteria: no exclusion criteria

Design outcomes

Primary

Measure	Time frame
Arterial PCO2;	—

Secondary

Measure	Time frame
Arterial PO2;pulse oxygen saturation;pH value;pH value;arterial oxygen saturation;breath times;heart times;	—

Countries

China

Contacts

Public ContactJingxi Zhang

Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital of the Second Military Medical University

jingxizhang2000@126.com+86 13917648401

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026